Medical Oncologist
Treatment costs
Ibrutinib Price in India: — Brand, Generic and Monthly Cost
Your oncologist has prescribed ibrutinib, and the first question most families ask is what it will cost each month. The answer depends on whether you take the branded originator or one of the Indian generics — and that difference is very large.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Generics cost far less — Indian-manufactured generic ibrutinib is available at a fraction of the branded originator price.
- Dose drives monthly spend — Your daily dose depends on your diagnosis. A higher dose means more capsules and a higher monthly cost.
- Generics are CDSCO-approved — Multiple Indian manufacturers hold CDSCO approval. Approved generics contain the same active molecule at the same strength.
- This is a long-term cost — Unlike a short chemotherapy course, ibrutinib is typically continued until the disease progresses or a side effect requires stopping.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
In India, generic ibrutinib costs roughly ₹15,000 to ₹60,000 a month, depending on your dose and the manufacturer. The branded originator costs significantly more. Multiple CDSCO-approved Indian generics are available and contain the same active molecule at the same strength.
What does ibrutinib cost in India?
| Option | Monthly cost (indicative, 2025) | Notes |
|---|---|---|
| Indian generic ibrutinib | ₹15,000 – ₹60,000 | Range reflects dose and manufacturer; multiple CDSCO-approved brands available |
| Branded originator ibrutinib | ₹1.5 lakh and above | Full retail price; manufacturer patient-assistance programme may apply |
| PMJAY / Aarogyasri (if eligible) | Nil or reduced copay | Oral drug coverage varies by scheme and state; confirm your diagnosis is included before starting |
| CGHS / ECHS / state government schemes | Reimbursable at approved rates | Approved rates may be below retail; retain all original prescriptions and bills for claims |
Why does the monthly cost vary so much?
Your dose is the biggest variable. Ibrutinib is prescribed at different daily amounts depending on whether you have chronic lymphocytic leukaemia, mantle cell lymphoma, Waldenström macroglobulinaemia or another condition. A higher daily dose means more capsules each month and a proportionally higher cost.
The choice between branded and generic is the second major factor. Indian manufacturers hold CDSCO approval for ibrutinib, and their products are the standard choice for most patients in India. The price gap between a generic and the originator brand can be several times over.
Pharmacy pricing adds smaller variation on top. A hospital pharmacy, a retail chain and an independent chemist may quote different figures for the same product. Asking for a comparison before your first purchase takes a few minutes and can matter over many months of treatment.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Care closer to home
35+ centres, so most treatment does not mean relocating to a metro.
How can you reduce what ibrutinib costs each month?
Ask your oncologist to prescribe by the generic name — ibrutinib — rather than by brand. A generic-name prescription lets the pharmacist dispense any CDSCO-approved manufacturer's version, and prices differ between brands.
If the branded version is needed and cost is a serious barrier, ask the CION team about the originator manufacturer's patient-assistance programme. These programmes are income-linked and can provide the drug at no cost or at a subsidised price to families who qualify.
Check your insurance policy before the first purchase. Some plans in India exclude oral cancer drugs entirely, others reimburse at a fixed percentage, and some group employer schemes cover them more broadly. Knowing your position in advance prevents a surprise rejection when you submit a claim.
What should you do before filling your first ibrutinib prescription?
- Confirm the prescription names ibrutinib, not a specific brandA generic-name prescription gives the pharmacist flexibility to offer you the most competitively priced CDSCO-approved version.
- Ask for prices from more than one pharmacyRetail, hospital and chain pharmacies may quote different amounts for the same generic. A short comparison before your first fill can reduce your spend over a long treatment course.
- Read your insurance policy for oral drug coverSome policies exclude oral cancer medicines. Check the exclusions section or call your insurer before purchasing, not after.
- Confirm PMJAY, CGHS, Aarogyasri or state-scheme eligibility if you hold a cardCoverage of specific oral drugs varies by scheme and state. Verify with the scheme office or your treating hospital, not a general helpline.
- Ask the CION team about the manufacturer patient-assistance programmeIf cost is a barrier to the branded version, your oncologist or the CION social work team can advise on eligibility and how to apply.
- Keep every original prescription and billInsurers and government reimbursement schemes typically require original documents. Photocopies are usually not accepted for first claims.
Explore 75 more Blood Cancer Targeted Medicines topics
Drug Deep Dive: Ibrutinib (Imbruvica)
- Diarrhoea, Joint Pain and Infection Risk on Ibrutinib
- Diet and Nutrition While on Ibrutinib
- Easy Bruising and Bleeding on Ibrutinib: What Is Normal and What Is Not
- Fertility, Pregnancy and Contraception on Ibrutinib
- How Does Ibrutinib Work? The BTK Inhibitor Explained
- How Long Does Ibrutinib Take to Work?
- How Long Will You Stay on Ibrutinib?
- Ibrutinib (Imbruvica, Ibrutix): The Complete Patient Guide
- Ibrutinib Interactions: Blood Thinners, Antifungals and Fish Oil
- Ibrutinib Myths: Lifelong Treatment, Bruising and 'It's Not Real Treatment'
- Ibrutinib Price in India: Brand, Generic and Monthly Cost
- Ibrutinib Side Effects: The Complete List and Timeline
- Ibrutinib Success Rate and Survival: An Honest Look at the Numbers
- Ibrutinib With Rituximab or Venetoclax: Continuous vs Fixed-Duration Therapy
- Ibrutinib in CLL, Mantle Cell Lymphoma and Waldenstrom's
- Ibrutinib in Elderly Patients and Those With Other Illnesses
- Ibrutinib vs Acalabrutinib vs Zanubrutinib: Comparing BTK Inhibitors
- Palpitations, Atrial Fibrillation and High Blood Pressure on Ibrutinib
- Surgery and Dental Procedures on Ibrutinib: The Bleeding Rule
- Taking Ibrutinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Ibrutinib
- When Ibrutinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Ibrutinib? CLL, Mantle Cell Lymphoma and Waldenstrom's Macroglobulinaemia
- Will Insurance or a Government Scheme Pay for Ibrutinib?
- Work, Travel and Daily Life on Ibrutinib
Drug Deep Dive: Imatinib (Gleevec)
- Adjuvant Imatinib After GIST Surgery: How Many Years?
- BCR-ABL PCR Monitoring: What 'Log Reduction' and 'MR4.5' Mean
- Can You Ever Stop Imatinib? Treatment-Free Remission Explained
- Diet and Nutrition While on Imatinib
- Fertility, Pregnancy and Contraception on Imatinib
- How Does Imatinib Work? The BCR-ABL and KIT Inhibitor Explained
- How Long Does Imatinib Take to Work?
- Imatinib (Gleevec, Veenat, Imatib): The Complete Patient Guide
- Imatinib Interactions: Paracetamol, Antacids and Herbal Medicines
- Imatinib Myths: Lifelong Dependence, Fertility and Generic Quality
- Imatinib Price in India: Brand, Generic and Monthly Cost
- Imatinib Side Effects: The Complete List and Timeline
- Imatinib Success Rate and Survival: An Honest Look at the Numbers
- Imatinib for GIST: How It Differs From CML Treatment
- Imatinib in Elderly Patients and Those With Other Illnesses
- Imatinib vs Nilotinib vs Dasatinib: Choosing a CML Drug
- Muscle Cramps and Bone Pain on Imatinib: What Actually Helps
- Nausea, Stomach Upset and Weight Gain on Imatinib
- Puffy Eyes and Swollen Legs on Imatinib: Managing Fluid Retention
- Taking Imatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Imatinib
- When Imatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Imatinib? Chronic Myeloid Leukaemia and GIST
- Will Insurance or a Government Scheme Pay for Imatinib?
- Work, Travel and Daily Life on Imatinib
Drug Deep Dive: Rituximab (MabThera)
- Diet and Nutrition While on Rituximab
- Drug, Food and Supplement Interactions With Rituximab
- Fertility, Pregnancy and Contraception on Rituximab
- Hepatitis B Reactivation and Rituximab: The Test You Must Not Skip
- How Does Rituximab Work? The Anti-CD20 Monoclonal Antibody Explained
- How Long Does Rituximab Take to Work?
- How Long Will You Stay on Rituximab?
- Low Antibodies and Repeated Infections After Rituximab
- MabThera vs Biosimilar Rituximab in India: Cost and Equivalence
- R-CHOP and Other Rituximab Combinations Explained
- Rituximab (MabThera, Ristova and biosimilars): The Complete Patient Guide
- Rituximab Infusion Day: Premedication, Duration and What to Expect
- Rituximab Infusion Reactions: Why the First Infusion Is Different
- Rituximab Maintenance: Two More Years of Infusions, and Why
- Rituximab Myths: Vaccines, Immunity and 'Permanent Damage'
- Rituximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Rituximab Side Effects: The Complete List and Timeline
- Rituximab Success Rate and Survival: An Honest Look at the Numbers
- Rituximab in Elderly Patients and Those With Other Illnesses
- Tests and Monitoring While You Are on Rituximab
- When Rituximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Rituximab? B-Cell Lymphoma and CLL
- Why the Same Drug Treats Arthritis and Lymphoma
- Will Insurance or a Government Scheme Pay for Rituximab?
- Work, Travel and Daily Life on Rituximab
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Is generic ibrutinib as effective as the branded version?
Yes. CDSCO-approved generic ibrutinib contains the same active molecule at the same strength and must meet the same bioequivalence standards as the originator. Approved generics from reputable Indian manufacturers are the standard of care for most patients in India. If you have a concern about a specific product, discuss it with your oncologist before switching.
Can I switch from the branded version to a generic mid-treatment?
Generally yes, and many patients do switch for cost reasons. Tell your oncologist before switching rather than after, so they can record the change and watch your response in the weeks that follow. You should not notice any clinical difference, but your team will want to know about any change in symptoms or side effects after the switch.
Does health insurance cover ibrutinib in India?
It depends entirely on your policy. Many individual and family floater plans in India exclude oral cancer drugs entirely or impose a sub-limit on them. Group employer policies sometimes cover them if oncology drugs are listed. Read the exclusions section of your policy document and call your insurer to confirm the position before your first purchase. Claims rejected after the fact are very difficult to overturn.
Is ibrutinib available at no cost under PMJAY or Ayushman Bharat?
PMJAY covers a wide range of cancer treatments, but coverage of specific oral drugs is subject to the scheme's formulary and your state's implementation, and this changes over time. Before relying on this, confirm with your PMJAY-empanelled hospital and the scheme helpline that your exact diagnosis and this specific drug are covered. Do not assume coverage — verify it in writing if possible.
Does the ibrutinib manufacturer offer a patient-assistance programme in India?
Yes, the originator manufacturer has a patient-support programme in India for patients who cannot afford the branded version at full retail price. Eligibility is income-linked. Ask your oncologist or the CION team to guide you through the application. Programme terms and availability change periodically, so your treating team will have the most current information.
Why is ibrutinib so much more expensive than older chemotherapy drugs?
Ibrutinib is a targeted therapy that required substantial research and development investment. The originator manufacturer holds a patent, which initially limited generic competition. In India, several manufacturers have since launched generics following patent proceedings, which is why the generic price is significantly lower than the originator. The originator continues to be priced to recover research costs, which is why the gap between branded and generic remains very large.